Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects
<p>Abstract</p> <p>Pharmacogenetics enables personalised therapy based on genetic profiling and is increasingly applied in drug discovery. Medicines are developed and used together with pharmacodiagnostic tools to achieve desired drug efficacy and safety margins. Genetic polymorphi...
Main Authors: | Matimba Alice, Del-Favero Jurgen, Van Broeckhoven Christine, Masimirembwa Collen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | http://www.humgenomics.com/content/3/2/169 |
Similar Items
-
CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
by: Immaculate M. Langmia, et al.
Published: (2021-07-01) -
Genetic Polymorphisms in CYP2 Gene Family in Bulgarian Individuals and their Clinical Implications
by: Yovinska S., et al.
Published: (2024-03-01) -
Genetic polymorphisms and drug metabolism
by: Vita Dolžan
Published: (2007-12-01) -
Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina
by: Vidović Stojko, et al.
Published: (2021-06-01) -
CYP2C19 genetic polymorphism in the Vietnamese population
by: Nhung Phuong Vu, et al.
Published: (2019-08-01)